
A CRISPR Breakthrough for Sickle Cell
Summary This article discusses the groundbreaking FDA approval of Casgevy, the world’s first CRISPR-based gene therapy for sickle cell disease. This innovative treatment offers a potential cure for this debilitating condition by editing patients’ blood […]